Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.mehy.2020.109827 http://scihub22266oqcxt.onion/10.1016/j.mehy.2020.109827 32447232!7217120!32447232     free     free     free       Med+Hypotheses 2020 ; 142 (ä): 109827 Nephropedia Template TP {{tp|p=32447232|t=2020. COVID-19: beta-thalassemia subjects immunised?|pdf=|usr=}}{{32447232}} gab.com Text COVID-19: beta-thalassemia subjects immunised JO: Med Hypotheses http://www.kidney.de/pget.php?&tw=1&pmid=32447232 #FOAvip The novel coronavirus pneumonia (COVID-19) is a contagious acute respiratory infectious disease whose causative agent has been demonstrated to be a novel virus of the coronavirus family, SARSCoV-2. A recent PRE-print study has showed a heme attack on the 1-beta chain of hemoglobin by COVID19. Beta-thalassemia results of a default in the hemoglobin beta-chain synthesis. 1,5% global population are heterozygotes for this disease. In this study, by a multiple linear regression, we have analyzed the evolution of COVID-19 infection in three Italian regions (Puglia, Sardinia, Sicilia) with different beta-thalassemic prevalences, in order to search a link. The results have showed that betathalassemic heterozygote population prevalence is correlated to immunity against COVID-19, by a regression. This paper is only for academic discussion, the hypotheses and conclusions needs to be confirmed by further research. Twit Text FOAVip COVID-19: beta-thalassemia subjects immunised ????Med Hypotheses http://www.kidney.de/pget.php?&tw=1&pmid=32447232 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32447232 #FOAvip English Wikipedia <ref>{{Cite pmid|32447232}}</ref> COVID-19: beta-thalassemia subjects immunised? #MMPMID32447232 Lansiaux E; Pebay PP; Picard JL; Son-Forget J Med Hypotheses 2020[Sep]; 142 (ä): 109827 PMID32447232show ga The novel coronavirus pneumonia (COVID-19) is a contagious acute respiratory infectious disease whose causative agent has been demonstrated to be a novel virus of the coronavirus family, SARSCoV-2. A recent PRE-print study has showed a heme attack on the 1-beta chain of hemoglobin by COVID19. Beta-thalassemia results of a default in the hemoglobin beta-chain synthesis. 1,5% global population are heterozygotes for this disease. In this study, by a multiple linear regression, we have analyzed the evolution of COVID-19 infection in three Italian regions (Puglia, Sardinia, Sicilia) with different beta-thalassemic prevalences, in order to search a link. The results have showed that betathalassemic heterozygote population prevalence is correlated to immunity against COVID-19, by a regression. This paper is only for academic discussion, the hypotheses and conclusions needs to be confirmed by further research. |Betacoronavirus[MESH] |COVID-19[MESH] |Coronavirus Infections/complications/*immunology[MESH] |Female[MESH] |Hemoglobins/analysis/chemistry[MESH] |Heterozygote[MESH] |Humans[MESH] |Immune System[MESH] |Immunization[MESH] |Italy/epidemiology[MESH] |Male[MESH] |Middle Aged[MESH] |Pandemics[MESH] |Pneumonia, Viral/complications/*immunology[MESH] |Prevalence[MESH] |Regression Analysis[MESH] |SARS-CoV-2[MESH] |Treatment Outcome[MESH]COVID-19: beta-thalassemia subjects immunised?(epmc).pdf DeepDyve Pubget Overpricing